首页> 外文期刊>Cellular and molecular biology >Detection of DNA amplification in human renal cell carcinoma cell lines using restriction landmark genomic scanning.
【24h】

Detection of DNA amplification in human renal cell carcinoma cell lines using restriction landmark genomic scanning.

机译:使用限制性地标基因组扫描检测人肾癌细胞系中DNA的扩增。

获取原文
获取原文并翻译 | 示例
           

摘要

Gene amplification, which has often been observed in various human cancers, appears to be associated with the development and progression of malignant phenotypes. However, in renal cell carcinoma (RCC), conventional analytic methods requiring specific primers and probes have revealed infrequent amplification of known oncogenes. We attempted to determine if gene amplification was truly uncommon in RCC. The genomic DNAs extracted from 5 human RCC cell lines were examined by restriction landmark genomic scanning (RLGS), a two-dimensional gel analysis which allows evaluation of approximately 2,000 radiolabelled DNA fragments. By this method, we detected 24 distinct spots commonly amplified in at least 2 RCC cell lines compared to normal kidneys. Comparing the present results with chromosomal assigned-RLGS, approximately one half of these DNA fragments proved to be located on chromosome 2, 5 or 7. Our data suggest that amplification of unknown genes is likely to occur in RCC cell lines.
机译:在各种人类癌症中经常观察到的基因扩增似乎与恶性表型的发生和发展有关。但是,在肾细胞癌(RCC)中,需要特定引物和探针的常规分析方法显示,已知致癌基因的扩增很少。我们试图确定基因扩增在RCC中是否真正罕见。通过限制性地标基因组扫描(RLGS),从二维凝胶分析中检测了从5个人类RCC细胞系中提取的基因组DNA,可以评估大约2,000个放射性标记的DNA片段。通过这种方法,与正常肾脏相比,我们检测到了至少在2个RCC细胞系中通常扩增的24个不同斑点。将本结果与染色体指定的RLGS进行比较,这些DNA片段的大约一半被证明位于2、5或7号染色体上。我们的数据表明,未知基因的扩增很可能在RCC细胞系中发生。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号